Advertisements



Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal

LONDON (Reuters) - For Christophe Weber, the boss of Japan's Takeda Pharmaceutical , securing a $62 billion deal last week to buy drugmaker Shire at the fifth time of asking was the easy bit......»»

Category: topSource: reutersMay 17th, 2018

Takeda weighs sale of Shire"s eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

Category: topSource: reutersSep 13th, 2018

Takeda to close Illinois office, move employees to Mass.

Takeda Pharmaceuticals has announced plans to close its U.S. sales office in Deerfield, Illinois, and relocate employees to the Boston area. The announcement comes on the heels of Japan-based Takeda's $62 billion deal to acquire Shire plc, one of the la.....»»

Category: topSource: bizjournalsSep 11th, 2018

Takeda gets key U.S. regulatory approval to buy Shire

Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc......»»

Category: topSource: reutersJul 10th, 2018

Takeda shareholder group aims to block $62B Shire deal

A group of Takeda Pharmaceutical shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: moneycentralJun 11th, 2018

Takeda shareholder group aims to block $62 billion Shire deal

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: reutersJun 11th, 2018

Takeda shareholders group say working to block $62 billion Shire deal

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is building support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: reutersJun 11th, 2018

Takeda global ambitions grow after Shire takeover

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

Category: videoSource: reutersMay 9th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.5.....»»

Category: topSource: usatodayMay 8th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) after the Japanese company raises the amount of cash in its offer to secure a recommendation. Silvia Antonioli reports......»»

Category: videoSource: reutersMay 8th, 2018

It"s Official: Takeda Reaches Agreement To Acquire Shire For $62 Billion

Initial reports of a pending M&A deal involving Shire PLC (ADR) (NASDAQ: SHPG) dates back to late March, when The Wall Street Journal reported that Japan-based Takeda Pharmaceuticals was interested in the Ireland-based pharmaceutical giant. read more.....»»

Category: blogSource: benzingaMay 8th, 2018

Takeda to buy pharma rival Shire in $62 billion deal

Takeda Pharmaceutical Co. on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker.....»»

Category: topSource: moneycentralMay 8th, 2018

Japan"s Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry......»»

Category: topSource: reutersMay 8th, 2018

Japan"s biggest ever deal: Takeda buys Shire for $62 billion

Japanese drugmaker Takeda has reached a $62 billion deal to buy rival Shire in the world's biggest takeover so far this year......»»

Category: topSource: cnnMay 8th, 2018

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to secure a recommendation......»»

Category: topSource: reutersMay 8th, 2018

Takeda Wins Battle for Shire With $62 Billion Deal

The offer from Japan’s Takeda, which values Shire at $62 billion, caps a monthslong battle for control of the European drugmaker......»»

Category: smallbizSource: wsjMay 8th, 2018

Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever

It's the largest-ever international takeover by any Japanese company, at a value of $62 billion. Japan’s Takeda Pharmaceutical is about to become.....»»

Category: europeSource: fortuneMay 8th, 2018

Takeda closes in on Shire deal with sweetened $64-billion offer

The transaction could result in a multinotch downgrade on Takeda's A1 rating, Moody's Investors Service wrote in a report on Wednesday.....»»

Category: topSource: business-standardApr 25th, 2018

Takeda Nears Shire Deal as Japanese Companies Chase Growth Overseas

Takeda is near a deal worth more than $60 billion to buy European drugmaker Shire, having raised its bid four times in a sign of how ardently Japan’s legacy companies are pursuing growth abroad as sales at home slow......»»

Category: smallbizSource: wsjApr 25th, 2018

Takeda is buying Adderall maker Shire for $64 billion in pharma"s biggest deal of the year

Reuters Takeda has reached a deal to buy Adderall drugmaker Shire for $64.3 billion.  The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda and Botox-maker Allergan.&.....»»

Category: topSource: businessinsiderApr 25th, 2018

Shire Inches Closer to Accepting Takeda"s $64 Billion Takeover

Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal......»»

Category: smallbizSource: wsjApr 25th, 2018